Boosting testosterone does not boost wellbeing, mood in ED patients
Adding testosterone to sildenafil treatment in men who have erectile dysfunction and low testosterone levels provides no additional benefit in terms of improving wellbeing or mood, show study findings. (Source: MedWire News - Urology)
Source: MedWire News - Urology - April 15, 2013 Category: Urology & Nephrology Source Type: news
Prostate calcification linked to LUTS
Moderate-to-marked prostatic calcification is an independent risk factor for moderate-to-severe lower urinary tract symptoms, report researchers. (Source: MedWire News - Urology)
Source: MedWire News - Urology - April 15, 2013 Category: Urology & Nephrology Source Type: news
Boosting testosterone does not boost wellbeing, mood in ED patients
Adding testosterone to sildenafil treatment in men who have erectile dysfunction and low testosterone levels provides no additional benefit in terms of improving wellbeing or mood, show study findings. (Source: MedWire News - Urology)
Source: MedWire News - Urology - April 15, 2013 Category: Urology & Nephrology Source Type: news
Prostate calcification linked to LUTS
Moderate-to-marked prostatic calcification is an independent risk factor for moderate-to-severe lower urinary tract symptoms, report researchers. (Source: MedWire News - Urology)
Source: MedWire News - Urology - April 15, 2013 Category: Urology & Nephrology Source Type: news
PSA test harms outweigh prostate cancer benefits in majority
Men should be warned that the chances of harm from screening with the prostate-specific antigen test outweigh the likelihood of benefit for most men, says the American College of Physicians in a guideline statement on prostate cancer screening. (Source: MedWire News - Urology)
Source: MedWire News - Urology - April 14, 2013 Category: Urology & Nephrology Source Type: news
Boosting testosterone does not boost wellbeing, mood in ED patients
Adding testosterone to sildenafil treatment in men who have erectile dysfunction and low testosterone levels provides no additional benefit in terms of improving wellbeing or mood, show study findings. (Source: MedWire News - Urology)
Source: MedWire News - Urology - April 10, 2013 Category: Urology & Nephrology Source Type: news
Reduced function in prostate cancer patients receiving radiotherapy
Men treated with a combination of intensity-modulated radiotherapy and androgen deprivation therapy for locally advanced prostate cancer suffer from long-term reductions in urinary, bowel, and sexual function, show study findings. (Source: MedWire News - Urology)
Source: MedWire News - Urology - April 8, 2013 Category: Urology & Nephrology Source Type: news
Diabetes severity holds clues to kidney stone risk
The severity of Type 2 diabetes is an important predictor for kidney stone disease, say researchers. (Source: MedWire News - Urology)
Source: MedWire News - Urology - April 8, 2013 Category: Urology & Nephrology Source Type: news
Reduced function in prostate cancer patients receiving radiotherapy
Men treated with a combination of intensity-modulated radiotherapy and androgen deprivation therapy for locally advanced prostate cancer suffer from long-term reductions in urinary, bowel, and sexual function, show study findings. (Source: MedWire News - Urology)
Source: MedWire News - Urology - April 8, 2013 Category: Urology & Nephrology Source Type: news
Diabetes severity holds clues to kidney stone risk
The severity of Type 2 diabetes is an important predictor for kidney stone disease, say researchers. (Source: MedWire News - Urology)
Source: MedWire News - Urology - April 8, 2013 Category: Urology & Nephrology Source Type: news
Holmium laser enucleation of the prostate effective in all ages
Holmium laser enucleation of the prostate seems to be a well tolerated and effective treatment option for individuals with benign prostatic hyperplasia, regardless of what age they are, report researchers. (Source: MedWire News - Urology)
Source: MedWire News - Urology - April 1, 2013 Category: Urology & Nephrology Source Type: news
Active surveillance an option for some low-risk prostate cancer patients
Active surveillance of individuals with very-low-risk prostate cancer who are also on 5 α-reductase inhibitor therapy for benign prostatic hyperplasia seems to be a viable therapeutic option, say researchers. (Source: MedWire News - Urology)
Source: MedWire News - Urology - April 1, 2013 Category: Urology & Nephrology Source Type: news
HPV vaccination should be complete before age 20
Human papillomavirus vaccination programs may only be effective when targeted at individuals aged under 20 years, show findings from a Swedish study. (Source: MedWire News - Urology)
Source: MedWire News - Urology - March 25, 2013 Category: Urology & Nephrology Source Type: news
